FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2975408641> ?p ?o ?g. }

• W2975408641 endingPage "2234" @default.
• W2975408641 startingPage "2229" @default.
• W2975408641 abstract "In 2017, a new two-step algorithm for the treatment of COPD was proposed. This algorithm was based on the severity of symptoms and phenotypes or treatable traits, and patient-specialised assessment targeting eosinophilic inflammation, chronic bronchitis, and frequent infections is recommended after exacerbation occurs despite maximal bronchodilation therapy. However, recent studies have revealed the clinical characteristics of patients who should have second controllers added, such as ICS. We again realized that treatable traits should be assessed and intervened for as early as possible. Moreover, the treatment algorithm is necessary to be adapted to the situation of clinical practice, taking into account the characteristics of the patients. The time to revise COPD treatment algorithm has come and we propose a new 3-step parallel approach for initial COPD treatment. After the diagnosis of COPD, the first assessment is to divide into two categories based on the usual clinical characteristics for patients with COPD and the specific clinical characteristics for each patient with concomitant disease. In the former, the assessment should be based on the level of dyspnea and the frequency of exacerbations. After the assessment, mono- or dual bronchodilator should be selected. In the latter, the assessment should be based on asthma characteristics, chronic bronchitis, and chronic heart failure. After the assessment, patients with asthmatic characteristics may consider treatment with ICS, while patients with chronic bronchitis may consider treatment with roflumilast and/or macrolide, while patients with chronic heart failure may consider treatment with selective β1-blocker. The 3-step parallel approach is completed by adding an additional therapy for patients with concomitant disease to essential therapy for patients with COPD. In addition, it is important to review the response around 4 weeks after the initial therapy. This COPD management proposal might be considered as an approach based on patients' clinical characteristics and on personalized therapy." @default.
• W2975408641 created "2019-10-03" @default.
• W2975408641 creator A5014801711 @default.
• W2975408641 creator A5052712328 @default.
• W2975408641 creator A5071831143 @default.
• W2975408641 creator A5073832849 @default.
• W2975408641 date "2019-09-01" @default.
• W2975408641 modified "2023-10-09" @default.
• W2975408641 title "<p>Time To Revise COPD Treatment Algorithm</p>" @default.
• W2975408641 cites W1595955343 @default.
• W2975408641 cites W1843924911 @default.
• W2975408641 cites W1863942808 @default.
• W2975408641 cites W1987881697 @default.
• W2975408641 cites W1995487477 @default.
• W2975408641 cites W2002726093 @default.
• W2975408641 cites W2009197337 @default.
• W2975408641 cites W2063070786 @default.
• W2975408641 cites W2076436577 @default.
• W2975408641 cites W2108357872 @default.
• W2975408641 cites W2124386100 @default.
• W2975408641 cites W2147475739 @default.
• W2975408641 cites W2155112552 @default.
• W2975408641 cites W2165033359 @default.
• W2975408641 cites W2167115187 @default.
• W2975408641 cites W2170309616 @default.
• W2975408641 cites W2172490363 @default.
• W2975408641 cites W2323342121 @default.
• W2975408641 cites W2427094903 @default.
• W2975408641 cites W2479879890 @default.
• W2975408641 cites W2510919056 @default.
• W2975408641 cites W2587393236 @default.
• W2975408641 cites W2590972178 @default.
• W2975408641 cites W2604501983 @default.
• W2975408641 cites W2610956233 @default.
• W2975408641 cites W2791250754 @default.
• W2975408641 cites W2792049838 @default.
• W2975408641 cites W2794019240 @default.
• W2975408641 cites W2794090707 @default.
• W2975408641 cites W2804166169 @default.
• W2975408641 cites W2805013685 @default.
• W2975408641 cites W2915816308 @default.
• W2975408641 cites W2920797638 @default.
• W2975408641 doi "https://doi.org/10.2147/copd.s219051" @default.
• W2975408641 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6776289" @default.
• W2975408641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31631994" @default.
• W2975408641 hasPublicationYear "2019" @default.
• W2975408641 type Work @default.
• W2975408641 sameAs 2975408641 @default.
• W2975408641 citedByCount "8" @default.
• W2975408641 countsByYear W29754086412020 @default.
• W2975408641 countsByYear W29754086412021 @default.
• W2975408641 countsByYear W29754086412022 @default.
• W2975408641 crossrefType "journal-article" @default.
• W2975408641 hasAuthorship W2975408641A5014801711 @default.
• W2975408641 hasAuthorship W2975408641A5052712328 @default.
• W2975408641 hasAuthorship W2975408641A5071831143 @default.
• W2975408641 hasAuthorship W2975408641A5073832849 @default.
• W2975408641 hasBestOaLocation W29754086411 @default.
• W2975408641 hasConcept C11413529 @default.
• W2975408641 hasConcept C126322002 @default.
• W2975408641 hasConcept C177713679 @default.
• W2975408641 hasConcept C1862650 @default.
• W2975408641 hasConcept C2776042228 @default.
• W2975408641 hasConcept C2776780178 @default.
• W2975408641 hasConcept C2777014857 @default.
• W2975408641 hasConcept C2778926808 @default.
• W2975408641 hasConcept C2779384505 @default.
• W2975408641 hasConcept C2779993553 @default.
• W2975408641 hasConcept C2781018748 @default.
• W2975408641 hasConcept C2992694001 @default.
• W2975408641 hasConcept C41008148 @default.
• W2975408641 hasConcept C71924100 @default.
• W2975408641 hasConceptScore W2975408641C11413529 @default.
• W2975408641 hasConceptScore W2975408641C126322002 @default.
• W2975408641 hasConceptScore W2975408641C177713679 @default.
• W2975408641 hasConceptScore W2975408641C1862650 @default.
• W2975408641 hasConceptScore W2975408641C2776042228 @default.
• W2975408641 hasConceptScore W2975408641C2776780178 @default.
• W2975408641 hasConceptScore W2975408641C2777014857 @default.
• W2975408641 hasConceptScore W2975408641C2778926808 @default.
• W2975408641 hasConceptScore W2975408641C2779384505 @default.
• W2975408641 hasConceptScore W2975408641C2779993553 @default.
• W2975408641 hasConceptScore W2975408641C2781018748 @default.
• W2975408641 hasConceptScore W2975408641C2992694001 @default.
• W2975408641 hasConceptScore W2975408641C41008148 @default.
• W2975408641 hasConceptScore W2975408641C71924100 @default.
• W2975408641 hasLocation W29754086411 @default.
• W2975408641 hasLocation W29754086412 @default.
• W2975408641 hasLocation W29754086413 @default.
• W2975408641 hasLocation W29754086414 @default.
• W2975408641 hasLocation W29754086415 @default.
• W2975408641 hasOpenAccess W2975408641 @default.
• W2975408641 hasPrimaryLocation W29754086411 @default.
• W2975408641 hasRelatedWork W2037843867 @default.
• W2975408641 hasRelatedWork W2077970371 @default.
• W2975408641 hasRelatedWork W2134832361 @default.
• W2975408641 hasRelatedWork W2186734693 @default.
• W2975408641 hasRelatedWork W2337350960 @default.

• next